Aleafia Health Announces Closing of $22.7 Million Bought Deal Offering
Tuesday, March 9, 2021, 9:21 AM ET
Aleafia Health Announces Closing of $22.7 Million Bought Deal Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, March 09, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) ("Aleafia Health" or the "Company") is pleased to announce that it has closed its previously announced bought deal offering (the "Offering") for a total issuance of 27,390,000 units of the Company ("Units") at a price per Unit of $0.83 for gross proceeds of $22.7 million, which includes a partial exercise of the over-allotment option. The offering was led by Cantor Fitzgerald Canada Corporation, as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters including Echelon Wealth Partners Inc. and Mackie Research Capital Corp. (together, the "Underwriters").